Clinical Trial Detail

NCT ID NCT01467115
Title INDUCTION CHEMOTHERAPY FOLLOWED BY CETUXIMAB AND RADIATION THERAPY FOR HEAD AND NECK CANCER
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors Drexel University
Indications

oral cavity cancer

oropharynx cancer

laryngeal squamous cell carcinoma

head and neck squamous cell carcinoma

hypopharynx cancer

Therapies

Leucovorin

Cisplatin + Docetaxel + Fluorouracil

Filgrastim

Cetuximab

Age Groups: adult

No variant requirements are available.